IP Library Granted Patent US 7,538,160
Granted Patent B2
US 7,538,160 · App. 11/173,705 · Granted May 26, 2009

Trifluorovinyl aromatic containing poly(alkyl ether) prepolymers

Assignee: Bausch & Lomb Incorporated
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,538,160
App. No.
11/173,705
Granted
May 26, 2009
Kind
B2
Abstract

The present invention provides prepolymers based on poly(alkyl ethers) having terminal triflurovinyl aromatic containing groups and polymers produced from such polymers. The prepolymers and polymers are useful as biomedical devices such as contact lenses or intraocular lenses.

Claims (19)

1. A poly(alkyl ether)prepolymer of the general formula T-(P) n -T wherein n is 1 to about 100,000, T is independently of the general formula

wherein L is an optional linking group and is independently a straight or branched C 1 -C 30 alkylene group, a C 3 -C 30 cycloalkylene group, a C 5 -C 30 aryl group, an ether group, a C 1 -C 20 ester group, an amide group, a siloxanyl, an arylsiloxanyl or a fluorosiloxanyl, R 1 independently represents one or more inertly substituted groups; X is independently a group which links the inertly substituted groups and the trifluorovinyl group; and P is independently an oxyalkylene radical of the general formula

wherein R 2 and R 3 are independently hydrogen, a straight or branched C 1 -C 6 alkyl group, a C 3 -C 30 cycloalkyl group, a C 5 -C 30 aryl group, a straight or branched C 1 -C 6 fluoroalkyl group, a C 3 -C 30 fluorocycloalkyl group, a C 5 -C 30 fluoroaryl group, an ether group, a C 1 -C 20 ester group, an amide group an amine group, fluorine, a vinyl group, or a hydroxyl group and m is 1 to about 10.

2. The poly(alkyl ether)prepolymer of claim 1 , wherein R 1 comprises a substituted or unsubstituted cyclic or polycyclic group optionally containing one or more heteroatoms and X is independently a bond, an oxygen atom, a sulfur atom, a carboxylic or thiocarboxylic ester group, a sulfone, a sulfoxide, perfluoroalkylene, perfluoroalkylene ether, alkylene, acetylene, a phosphine, a carbonyl or thiocarbonyl group; seleno; telluro; nitrido; a silanediyl group, a trisilanediyl group, a tetrasilanetetrayl group, a siloxanediyl group, a disiloxanediyl group, a trisiloxyl group, a trisilazanyl group, a silythio group, or a boranediyl group.

3. The poly(alkyl ether)prepolymer of claim 1 , wherein X is O, R 1 is one or more aromatic groups selected from the group consisting of

wherein R is independently hydrogen, a C 1 -C 20 alkyl group, a hydroxyl group, a C 1 -C 20 carboxylic acid group, a C 1 -C 20 ester group, a C 1 -C 20 alkoxy group, CO 2 − , SO 3 − , PO 3 − , OPO 3 2− , F, Br, I, NA 2 or NA 3 + wherein A is independently hydrogen, a C 1 -C 20 alkyl group, a hydroxyl group, a C 1 -C 20 carboxylic acid group, a C 1 -C 20 ester group, or a C 1 -C 20 alkoxy group, or two R groups together with the carbon atom to which they are bonded are joined together to form a cyclic structure optionally containing one or more heterocyclic groups; R 4 is a bond, a C 1 -C 20 alkylene or haloalkylene group optionally containing ether or ester linkages and wherein the X group and either the L or P group may independently be bonded to the aromatic group either ortho, meta and/or para with respect one another.

4. The poly(alkyl ether)prepolymer of claim 1 , wherein R 2 and R 3 are independently a straight or branched C 1 -C 6 alkyl group.

5. The poly(alkyl ether)prepolymer of claim 1 , wherein R 2 and R 3 are independently a straight or branched C 1 -C 6 fluoroalkyl group.

6. The poly(alkyl ether)prepolymer of claim 1 , wherein n is 3 to about 10,000, X is O, R 2 and R 3 are independently a straight or branched C 1 -C 6 alkyl group and the oxyalkylene units are formed as random copolymers.

7. The poly(alkyl ether)prepolymer of claim 1 , wherein n is 3 to about 10,000, X is O, R 2 and R 3 are independently a straight or branched C 1 -C 6 alkyl group and the oxyalkylene units are formed as block copolymers.

8. The poly(alkyl ether)prepolymer of claim 1 , wherein n is 3 to about 10,000, X is O, R 2 and R 3 are independently a straight or branched C 1 -C 6 fluoroalkyl group and the oxyalkylene units are formed as random copolymers.

9. The poly(alkyl ether)prepolymer of claim 1 , wherein n is 3 to about 10,000, X is O, R 2 and R 3 are independently a straight or branched C 1 -C 6 fluoroalkyl group and the oxyalkylene units are formed as block copolymers.

10. The poly(alkyl ether)prepolymer of claim 1 , which is selected from the group consisting of

wherein x, y and z are independently 0 and at least 1 with x+y+z being from 1 to equal to or less than about 10,000 and R 5 is independently hydrogen or a C 1 -C 4 alkyl group; and

wherein m and n are independently 0 and at least 1 with m+n being from 1 to equal to or less than about 10,000.

11. A biomedical device comprising the poly(alkyl ether)prepolymer of claim 1 .

12. The biomedical device of claim 11 , which is an ophthalmic lens.

13. The biomedical device of claim 12 , wherein the ophthalmic lens is a contact lens.

14. The biomedical device of claim 13 , wherein the contact lens is a rigid gas permeable lens.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
NOTICE OF SUCCESSION OF AGENCY Recorded Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
SECURITY AGREEMENT Recorded Sep 4, 2013
From: BAUSCH & LOMB INCORPORATED
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 031156/0508 →
RELEASE OF SECURITY INTEREST Recorded Aug 13, 2013
From: CITIBANK N.A., AS ADMINISTRATIVE AGENT
To: WP PRISM INC. (N/K/A BAUSCH & LOMB HOLDINGS INC.); BAUSCH & LOMB INCORPORATED; ISTA PHARMACEUTICALS
Reel/Frame 030995/0444 →
SECURITY AGREEMENT Recorded Aug 6, 2012
From: BAUSCH & LOMB INCORPORATED; EYEONICS, INC.
To: CITIBANK N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 028728/0645 →
RELEASE OF SECURITY INTEREST Recorded Aug 5, 2012
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 028726/0142 →
SECURITY AGREEMENT Recorded Aug 28, 2009
From: BAUSCH & LOMB INCORPORATED; B&L CRL INC.; B&L CRL PARTNERS L.P.; B & L DOMESTIC HOLDINGS CORP.; B&L FINANCIAL HOLDINGS, INC.; B&L SPAF INC.; B&L VPLEX HOLDINGS, INC.; BAUSCH & LOMB CHINA, INC.; BAUSCH & LOMB INTERNATIONAL INC.; BAUSCH & LOMB REALTY CORPORATION; BAUSCH & LOMB SOUTH ASIA, INC.; BAUSCH & LOMB TECHNOLOGY CORPORATION; IOLAB CORPORATION; RHC HOLDINGS, INC.; SIGHT SAVERS, INC.; WILMINGTON MANAGEMENT CORP.; WILMINGTON PARTNERS L.P.; B&L MINORITY DUTCH HOLDINGS LLC; EYEONICS, INC.
To: CREDIT SUISSE
Reel/Frame 023163/0134 →
SECURITY AGREEMENT Recorded Nov 16, 2007
From: BAUSCH & LOMB INCORPORATED; B&L CRL INC.; B&L CRL PARTNERS L.P.; B & L DOMESTIC HOLDINGS CORP.; B&L FINANCIAL HOLDINGS CORP.; B&L SPAF INC.; B&L VPLEX HOLDINGS, INC.; BAUSCH & LOMB CHINA, INC.; BAUSCH & LOMB INTERNATIONAL INC.; BAUSCH & LOMB TECHNOLOGY CORPORATION; BAUSCH & LOMB REALTY CORPORATION; BAUSCH & LOMB SOUTH ASIA, INC.; SIGHT SAVERS, INC.; WILMINGTON MANAGEMENT CORP.; WILMINGTON PARTNERS L.P.; B&L MINORITY DUTCH HOLDINGS LLC; IOLAB CORPORATION; RHC HOLDINGS, INC.; WP PRISM, INC.
To: CREDIT SUISSE
Reel/Frame 020122/0722 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 1, 2005
From: SCHORZMAN, DEREK; SALAMONE, JOSEPH C.
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 016725/0942 →
Continuity (1)
Related Publication 20070004897A1 · Jan 4, 2007